Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mayukh Sukhatme currently holds 18,677,617 shares of Roivant Sciences Ltd. (ROIV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mayukh Sukhatme has been a net seller of ROIV stock. They have purchased $0 and sold $38.5M worth of shares.
Mayukh Sukhatme's most recent insider trade was on Mar 31, 2026, when they sold 187,512 shares at $27.70 per share.
Mayukh Sukhatme serves as Executive at Roivant Sciences Ltd. (ROIV). They have executed 31 insider transactions totaling $38.5M over their tenure at the company.
Mayukh Sukhatme holds the position of Executive at Roivant Sciences Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Mayukh Sukhatme has shown a selling trading pattern, with $0 in total purchases and $38.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mayukh Sukhatme was on Dec 31, 2025, when they sold $31.1M worth of ROIV shares. This transaction involved 1,430,882 shares at $21.71 per share.
Mayukh Sukhatme currently owns 18,677,617 shares of Roivant Sciences Ltd. (ROIV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mayukh Sukhatme's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mayukh Sukhatme has 31 Form 4 filings on record as an insider at Roivant Sciences Ltd..
Set alerts for Mayukh Sukhatme and 40,000+ other insiders.